Online citations, reference lists, and bibliographies.
← Back to Search

The Influence Of CCL3L1 Gene-Containing Segmental Duplications On HIV-1/AIDS Susceptibility

E. González, H. Kulkarni, Hector H Bolivar, A. Mangano, R. Sanchez, G. Cataño, R. J. Nibbs, B. Freedman, M. P. Quinones, M. Bamshad, K. Murthy, B. Rovin, W. Bradley, R. Clark, S. A. Anderson, R. O'Connell, B. Agan, S. S. Ahuja, R. Bologna, L. Sen, M. Dolan, S. Ahuja
Published 2005 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Segmental duplications in the human genome are selectively enriched for genes involved in immunity, although the phenotypic consequences for host defense are unknown. We show that there are significant interindividual and interpopulation differences in the copy number of a segmental duplication encompassing the gene encoding CCL3L1 (MIP-1αP), a potent human immunodeficiency virus–1 (HIV-1)–suppressive chemokine and ligand for the HIV coreceptor CCR5. Possession of a CCL3L1 copy number lower than the population average is associated with markedly enhanced HIV/acquired immunodeficiency syndrome (AIDS) susceptibility. This susceptibility is even greater in individuals who also possess disease-accelerating CCR5 genotypes. This relationship between CCL3L1 dose and altered HIV/AIDS susceptibility points to a central role for CCL3L1 in HIV/AIDS pathogenesis and indicates that differences in the dose of immune response genes may constitute a genetic basis for variable responses to infectious diseases.
This paper references
Gene copy number regulates the production of the human chemokine CCL3‐L1
J. R. Townson (2002)
Nat. Rev. Cancer
K Huebner (2001)
Macrophage inflammatory protein-1.
P. Menten (2002)
Mol. Psychiatry
J Veenstra-Vander (2004)
Nat. Genet
J N Ferguson (2000)
Am. J. Hum. Genet
L E Vissers (2003)
D. Wilkin (2001)
J. Hum. Genet
K Bhalla (2004)
Nature Rev. Genet
R V Samonte (2002)
Nat. Rev. Genet
L Feuk (2006)
Genome Res
W J Kent (2002)
Nat. Genet
C Shaw-Smith (2006)
Genetic acceleration of AIDS progression by a promoter variant of CCR5.
M. Martin (1998)
Galen Breningstall (2002)
European Chromosome 16 Tuberous Sclerosis Consortium
Mol. Psychiatry
J A Vorstman (2006)
Nat. Genet
C M Durand (2007)
J. Am. Soc. Nephrol
T Igarashi (2001)
CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.
J. Salkowitz (2003)
RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression.
W. Paxton (2001)
Segmental duplications and the evolution of the primate genome
R. V. Samonte (2002)
Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.
A. Mangano (2001)
Genome Res
R Lucito (2003)
J. Infect. Dis
A Mangano (2001)
Nature Am. J. Hum. Genet
T J Aitman (2006)
Cytokine Growth Factor Rev
P Menten (2002)
Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia
V. Gandemer (2007)
J. Acquir. Immune Defic. Syndr
J Reynes (2003)
Am. J. Hum. Genet
J K Pritchard (2001)
Nat. Genet
J A Iafrate (2004)
Low CD4+ T-cell surface CCR5 density as a cause of resistance to in vivo HIV-1 infection.
J. Reynes (2003)
J. Exp. Med
L Wu (1997)
The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy.
J. Tang (2003)
Autism Dev. Disord
M Ghaziuddin (1999)
Eur. J. Hum. Genet
S M Klauck (2006)
Production of beta-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1beta are associated with a decreased risk of HIV disease progression.
H. Ullum (1998)
Epidemiologic Research: Principles and Quantitative Methods.
S. Pocock (1982)
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
L. Wu (1997)
C-C chemokines, pivotal in protection against HIV type 1 infection.
D. Zagury (1998)
Hematol. Oncol. Clin. North Am
D L Weed (2000)
Economic Control of Quality of Manufactured Product.
A. R. Crathorne (1931)
Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors
L. Baumbusch (2007)
Nat. Genet
D A Koolen (2006)
Recent Segmental Duplications in the Human Genome
J. Bailey (2002)
J. Infect. Dis
W A Paxton (2001)
Eur. J. Immunol
J R Townson (2002)
J. Med. Genet
M L Jacquemont (2006)
Nat. Genet
R E Amir (1999)
J. Clin. Psychiatry
E Fombonne (2005)
beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques.
J. Heeney (1998)
AC Tose (1993)
Materials and methods are available as supporting material on Science Online
Control of HIV-1 infection by soluble factors of the immune response
Anthony L. DeVico (2004)
Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status.
A. Garzino-Demo (1999)
Nature Rev. Microbiol
A L Devico (2004)
J. Med. Genet
C Shaw-Smith (2004)
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection
J. Mellors (1997)
疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A
宁北芳 (2005)
Clin. Immunol
J R Salkowitz (2003)
Nat. Genet
A J Sharp (2006)
J. Biol. Chem
S Mummidi (2000)
Epidemiologic evidence and causal inference.
D. Weed (2000)
Spontaneous production of RANTES and antigen‐specific IFN‐γ production in macaques vaccinated with SHIV‐4 correlates with protection against SIVsm challenge
R. Ahmed (2002)
Bootstrap Methods and their Application
A. C. Davison (1997)
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes.
E. González (1999)
Ann. Intern. Med
J W Mellors (1997)
Nat. Genet
A J Iafrate (2004)
J. Infect. Dis
H Ullum (1998)
is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research Because of space References
Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA
S. Mummidi (2000)

This paper is referenced by
Infectogenomics: Insights from the Host Genome into Infectious Diseases
P. Kellam (2006)
Concurrent transposition of distal 6p and 20q to the 22q telomere: a recurrent benign chromosomal variant.
M. Bonaglia (2008)
Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen
H. Blauw (2008)
Copy Number Variants: Distribution in Patients with Coronary Atherosclerosis
K. Gancheva (2009)
Copy number variants, diseases and gene expression.
C. N. Henrichsen (2009)
Chemokine production in HIV-1 infection and pulmonary tuberculosis
Samantha L. Donninger (2009)
Genetic Susceptibility to Gastrointestinal Cancer: Minireview of the Genomewide Studies
Masayoshi Tokuoka (2009)
Rare variation at the TNFAIP3 locus and susceptibility to rheumatoid arthritis
John BowesRobert (2010)
Barcode technology in yeast: application to pharmacogenomics.
D. Delneri (2010)
NeuroAIDS in the Asia Pacific Region
E. Wright (2011)
Using GWAS Data to Identify Copy Number Variants Contributing to Common Complex Diseases
Sebastian K. Zollner (2009)
Copy number variation and susceptibility to human disorders (Review).
B. S. Shastry (2009)
The genetic architecture of neuropsychiatric traits: mechanism, polygenicity, and genome function
E. Gamazon (2016)
Host and Viral Factors Influencing the Pathogenesis of HIV-Associated Neurocognitive Disorders
S. Jayadev (2009)
Identification of new variants within the two functional genes CCL3 and CCL3L encoding the CCL3 (MIP‐1α) chemokine: implications for HIV‐1 infection
M. Paximadis (2009)
Platelets in Immune Response to Virus and Immunopathology of Viral Infections
E. Hottz (2018)
Multiply to conquer: Copy number variations at Ppd-B1 and Vrn-A1 facilitate global adaptation in wheat
T. Würschum (2015)
β-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans.
R. Hardwick (2012)
Diagnosis and management of acute HIV infection.
N. Zetola (2007)
DNA variations in human and medical genetics: 25 years of my experience
Y. Nakamura (2009)
SLAMF7 Is a Critical Negative Regulator of IFN-α–Mediated CXCL10 Production in Chronic HIV Infection
P. O'Connell (2019)
Copy number alterations among mammalian enzymes cluster in the metabolic network.
Michaël Bekaert (2011)
Medizinische Genetik: Copy number variants (CNV) Krankheitsverursachend, Risikofaktor oder bedeutungslose Normvariante?
D. Bartholdi (2008)
Bases Genètiques de l'Osteoporosi: Estudi del gen "LRP5".
L. Calpena (2010)
Completing the map of human genetic variation
E. Eichler (2007)
Étude des polymorphismes génétiques des gènes des cytokines dans les lymphomes hodgkiniens
H. Ghesquières (2010)
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE ε4/ε4 genotype accelerates HIV disease progression
T. Burt (2008)
The Coalescent with Selection on Copy Number Variants
Kosuke M. Teshima (2012)
Host Factors and HIV-1 Replication: Clinical Evidence and Potential Therapeutic Approaches
Mariana Santa-Marta (2013)
Microarray Analysis of HIV Resistant Female Sex Workers Reveal a Gene Expression Signature Pattern Reminiscent of a Lowered Immune Activation State
E. Songok (2012)
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals
Sara Yahyaei (2016)
Multicolor super-resolution DNA imaging for genetic analysis.
Murat Baday (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar